Identification of key molecular targets correlation with breast cancer through bioinformatic methods.
To find the key molecular targets of breast cancer for targeted treatment and improve the survival rate. Overlapped difference expression genes in three datasets in weighted gene co-expression network analyses (WGCNA) module and MetaDE.ES analysis were identified. Combined with the prognosis information (time, death, status and RS) in GSE42568, the single-factor cox regression analysis was used to screen the genes significantly related to the prognosis in the target gene set. A total of 13 optimal genes combinations with significantly correlated prognosis were obtained, including SSPN, NELL2, AGTR1, NRIP3, IKZF2, NAT1, CXCL12, NPY1R, PRAME, PPP1R1B, CRISP3, NMU and GSTP1. In addition, there was a significant correlation between the samples given by the prognostic prediction system and the validation dataset (GSE20685 and TCGA), with the P values of 0.0299 in GSE20685 and 1.461e-5 in TCGA, and AUROC of 0.942 and 0.923, respectively. RS-related differentially expressed genes between high-risk and low-risk groups was significantly related to biological processes such as cell period and hormone stimulation response, and was also significantly involved in KEGG pathways such as cell period, PPAR signaling pathway and cancer pathway. By predicting the survival risk of breast cancer patients based on the 13 optimal genes, the high risk patients would be early detected, and it would help us formulate appropriate treatment plan for patients.